PRESS RELEASE published on 07/07/2023 at 14:00, 2 years 11 months ago OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
PRESS RELEASE published on 07/07/2023 at 13:00, 2 years 11 months ago Bausch Health Enters Into $600 Million Financing Facility With KKR
PRESS RELEASE published on 06/30/2023 at 14:30, 2 years 11 months ago Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
PRESS RELEASE published on 06/19/2023 at 14:00, 3 years ago Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
PRESS RELEASE published on 06/06/2023 at 14:00, 3 years ago Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
PRESS RELEASE published on 05/18/2023 at 14:00, 3 years 1 month ago New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
PRESS RELEASE published on 05/17/2023 at 19:20, 3 years 1 month ago U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
PRESS RELEASE published on 05/17/2023 at 14:00, 3 years 1 month ago Bausch Health Announces 2023 Annual Meeting of Shareholder Results
PRESS RELEASE published on 05/10/2023 at 14:00, 3 years 1 month ago Bausch Health Observes Mental Health Awareness Month
PRESS RELEASE published on 05/08/2023 at 14:00, 3 years 1 month ago Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
Published on 06/27/2026 at 01:40, 7 hours 16 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 56 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 56 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 10 hours 6 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 41 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 51 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 52 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 20 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 20 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 29 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 15 hours 11 minutes ago Descriptif du programme de rachat d'actions
